$1.28
-0.01-0.88%
At Close: -
$1.29
0.010.78%
After Hours: Jul 12, 6:59 PM EDT
15 minutes delayed
RenovoRx
RNXTNASDAQ
RenovoRx (NASDAQ:RNXT) Stock Quotes, Forecast and News Summary
RenovoRx Stock (NASDAQ: RNXT) stock price, news, charts, stock research, profile.
| Open | $1.30 |
| Close | $1.28 |
| Volume / Avg. | 18.52K / 39.63K |
| Day Range | 1.26 - 1.31 |
| 52 Wk Range | 0.53 - 2.35 |
| Market Cap | $30.66M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 55 |
| Short Interest | 0.19% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About RenovoRx Inc
Sector
Health Care
Industry
Biotechnology
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combinati...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy RenovoRx (RNXT) stock?
You can purchase shares of RenovoRx (NASDAQ:RNXT) through any online brokerage.
Who are RenovoRx (RNXT) competitors?
Other companies in RenovoRx’s space includes: NKGen Biotech (NASDAQ:NKGN), Acurx Pharmaceuticals (NASDAQ:ACXP), Gain Therapeutics (NASDAQ:GANX), Immuneering (NASDAQ:IMRX) and Bolt Biotherapeutics (NASDAQ:BOLT).
What is the target price for RenovoRx (RNXT) stock?
There is no analysis for RenovoRx.
What is the forecast for RenovoRx (RNXT) stock?
RenovoRx has a consensus price target of $10.25.
Current stock price for RenovoRx (RNXT)?
The stock price for RenovoRx (NASDAQ: RNXT) is $1.29 last updated July 12, 2024 at 6:59 PM EDT.
Does RenovoRx (RNXT) pay a dividend?
There are no upcoming dividends for RenovoRx.
When is RenovoRx (NASDAQ:RNXT) reporting earnings?
RenovoRx’s Q2 earnings are confirmed for Thursday, August 15, 2024.
Is RenovoRx (RNXT) going to split?
There is no upcoming split for RenovoRx.
What sector and industry does RenovoRx (RNXT) operate in?
RenovoRx is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.